Skip to main content

Table 4 Associations between TACE-Iodine 125 treatment and mortality and recurrence in patients with early-intermediate HCC after PSM

From: Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma

Characteristics

Mortality

Recurrence

Adjusted HR (95%CI)

P value

Adjusted HR (95%CI)

P value

Overall

TACE-RFA

Reference

 

Reference

 

TACE-Iodine 125

0.766 (0.384,1.530)

0.450

1.220 (0.711,2.093)

0.470

  1. Abbreviations: TACE Transarterial chemoembolization; RFA Radiofrequency ablation; BCLC Barcelona Clinic Liver Cancer